retatrutide peptide compounding pharmacy Therapy GLP-3 (RT) - Simon's Compounding

Zhang Y, Sun B, Feng D, Hu H, Chu M, Qu Q, et al

Participants using tirzepatide 15 mg lost a mean of 22.5% of body weight versus 2.4% in the placebo group over 72 weeks - the largest weight reduction ever documented in a Phase 3 placebo-controlled trial for a pharmacological weight management agent at the time of publication, a figure that represented a significant outcome in the drug class at the time of publication

As research continues to evolve, consumers benefit most from evidence-based decision-making that balances desire for aesthetic improvement with commitment to safety and overall health.

Adjusting as you progress Your tracking needs will change as you progress through the protocol